ArticleOncotarget2017

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines.

Shota Fukuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.